Workflow
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
ALLRAllarity Therapeutics(ALLR) Newsfilter·2024-04-17 21:10